✦ LIBER ✦

APCGenotype Is Not a Prognostic Factor in Familial Adenomatous Polyposis Patients With Colorectal Cancer

✍ Scribed by Lucio Bertario; Antonio Russo; Paola Sala; Liliana Varesco; Rosella Crucianelli; Milo Frattini; Marco A. Pierotti; Paolo Radice; On behalf of the Hereditary Colorectal Tumors Registry (see Appendix)

Publisher: Springer
Year: 2004
Tongue: English
Weight: 110 KB
Volume: 47
Category: Article
ISSN: 0012-3706
DOI: 10.1007/s10350-004-0652-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thyroid Cancer in Patients with Familial

Thyroid Cancer in Patients with Familial Adenomatous Polyposis

✍ Nancy D. Perrier; Jon A. van Heerden; John R. Goellner; E. Dillwyn Williams; Hos 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 999 KB

Development of duodenal cancer in a pati

Development of duodenal cancer in a patient with familial adenomatous polyposis

✍ Hiroshi Kashiwagi; Kyotaro Kanazawa; Masaru Koizumi; Hiroyuki Shibusawa; Allan D 📂 Article 📅 2000 🏛 Springer Japan 🌐 English ⚖ 761 KB

Mutation analysis of the adenomatous pol

Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer

✍ Clara Ruiz-Ponte; Ana Vega; Angel Carracedo; Francisco Barros 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

Germline mutations in the tumor-suppresor APC gene are associated with hereditary familial adenomatous polyposis (FAP) and somatic mutations are common in sporadic colorectal cancer. In this study, we report the identification of three novel germline mutations: 1682-1683insA, 3252-3253insAT, 3544A>T

Results after restorative proctocolectom

Results after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and coexisting colorectal cancer

✍ Y. Ziv; Dr J. M. Church; J. R. Oakley; E. McGannon; T. K. Schroeder; V. F. Fazio 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 317 KB 👁 2 views

SMAD7 is a prognostic marker in patients

SMAD7 is a prognostic marker in patients with colorectal cancer

✍ Jean-Louis Boulay; Gabriele Mild; Adam Lowy; Juergen Reuter; Magali Lagrange; Lu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 82 KB

## Abstract Chromosomal region 18q21 is frequently deleted in colorectal cancer (CRC) and is associated with poor prognosis. Potential tumor suppressor mechanisms altered by 18q21 deletion include mediation of TGFβ signaling by SMADs. Following the definition of __SMAD4__ deletion as a negative pre

Is there a role for clinical prognostic

Is there a role for clinical prognostic factors in staging patients with colorectal cancer?

✍ Dr. S. David Nathanson 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 712 KB

## Abstract The clinician treating colorectal cancer (CRC) should be able to predict which patients will live and which will die from their tumor. Many prognostic variables, significant in retrospective analyses, are never formally used in staging. The resultant imperfection of clinical predictions